These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19460634)

  • 1. A quantitative assessment of gene expression (QAGE) reveals differential overexpression of DOPEY2, a candidate gene for mental retardation, in Down syndrome brain regions.
    Rachidi M; Delezoide AL; Delabar JM; Lopes C
    Int J Dev Neurosci; 2009 Jun; 27(4):393-8. PubMed ID: 19460634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C21orf5, a human candidate gene for brain abnormalities and mental retardation in Down syndrome.
    Rachidi M; Lopes C; Delezoide AL; Delabar JM
    Cytogenet Genome Res; 2006; 112(1-2):16-22. PubMed ID: 16276086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C21orf5, a new member of Dopey family involved in morphogenesis, could participate in neurological alterations and mental retardation in Down syndrome.
    Rachidi M; Lopes C; Costantine M; Delabar JM
    DNA Res; 2005; 12(3):203-10. PubMed ID: 16303751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differentially expressed C21orf5 gene in the medial temporal-lobe system could play a role in mental retardation in Down syndrome and transgenic mice.
    Lopes C; Chettouh Z; Delabar JM; Rachidi M
    Biochem Biophys Res Commun; 2003 Jun; 305(4):915-24. PubMed ID: 12767918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
    Rachidi M; Lopes C
    Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart.
    Fuentes JJ; Pritchard MA; Planas AM; Bosch A; Ferrer I; Estivill X
    Hum Mol Genet; 1995 Oct; 4(10):1935-44. PubMed ID: 8595418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networks.
    Ling KH; Hewitt CA; Tan KL; Cheah PS; Vidyadaran S; Lai MI; Lee HC; Simpson K; Hyde L; Pritchard MA; Smyth GK; Thomas T; Scott HS
    BMC Genomics; 2014 Jul; 15(1):624. PubMed ID: 25052193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart.
    Mao R; Wang X; Spitznagel EL; Frelin LP; Ting JC; Ding H; Kim JW; Ruczinski I; Downey TJ; Pevsner J
    Genome Biol; 2005; 6(13):R107. PubMed ID: 16420667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models.
    Galdzicki Z; Siarey R; Pearce R; Stoll J; Rapoport SI
    Brain Res Brain Res Rev; 2001 Apr; 35(2):115-45. PubMed ID: 11336779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the transcription factor ETS2 in brain of patients with Down syndrome--evidence against the overexpression-gene dosage hypothesis.
    Greber-Platzer S; Schatzmann-Turhani D; Cairns N; Balcz B; Lubec G
    J Neural Transm Suppl; 1999; 57():269-81. PubMed ID: 10666682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.
    Altafaj X; Dierssen M; Baamonde C; Martí E; Visa J; Guimerà J; Oset M; González JR; Flórez J; Fillat C; Estivill X
    Hum Mol Genet; 2001 Sep; 10(18):1915-23. PubMed ID: 11555628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comprehensive Analyses of Molecules with Altered Expression in the Brain of a Mouse Model of Down Syndrome for Identification of Pharmacotherapeutic Targets].
    Ishihara K
    Yakugaku Zasshi; 2017; 137(7):807-810. PubMed ID: 28674291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial and temporal localization during embryonic and fetal human development of the transcription factor SIM2 in brain regions altered in Down syndrome.
    Rachidi M; Lopes C; Charron G; Delezoide AL; Paly E; Bloch B; Delabar JM
    Int J Dev Neurosci; 2005 Aug; 23(5):475-84. PubMed ID: 15946822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression analysis of cultured amniotic fluid cell with Down syndrome by DNA microarray.
    Chung IH; Lee SH; Lee KW; Park SH; Cha KY; Kim NS; Yoo HS; Kim YS; Lee S
    J Korean Med Sci; 2005 Feb; 20(1):82-7. PubMed ID: 15716609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of FABP7 in Down syndrome fetal brains is associated with PKNOX1 gene-dosage imbalance.
    Sánchez-Font MF; Bosch-Comas A; Gonzàlez-Duarte R; Marfany G
    Nucleic Acids Res; 2003 Jun; 31(11):2769-77. PubMed ID: 12771203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome.
    Rachidi M; Lopes C
    Am J Intellect Dev Disabil; 2010 Mar; 115(2):83-112. PubMed ID: 20441388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of trisomic proteins in Down syndrome model systems.
    Spellman C; Ahmed MM; Dubach D; Gardiner KJ
    Gene; 2013 Jan; 512(2):219-25. PubMed ID: 23103828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global differential expression of genes located in the Down Syndrome Critical Region in normal human brain.
    Montoya JC; Fajardo D; Peña A; Sánchez A; Domínguez MC; Satizábal JM; García-Vallejo F
    Colomb Med (Cali); 2014; 45(4):154-61. PubMed ID: 25767303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome.
    Shukkur EA; Shimohata A; Akagi T; Yu W; Yamaguchi M; Murayama M; Chui D; Takeuchi T; Amano K; Subramhanya KH; Hashikawa T; Sago H; Epstein CJ; Takashima A; Yamakawa K
    Hum Mol Genet; 2006 Sep; 15(18):2752-62. PubMed ID: 16891409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.